VTRS

Viatris (VTRS)

Viatris Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VTRS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	20 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTRS	Viatris Inc
2024/06/03	19 : 59	PR Newswire (US)	Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors	NASDAQ:VTRS	Viatris Inc
2024/05/31	19 : 59	PR Newswire (US)	Viatris to Participate in the Jeffries Global Healthcare Conference	NASDAQ:VTRS	Viatris Inc
2024/05/29	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/05/29	05 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTRS	Viatris Inc
2024/05/21	19 : 59	PR Newswire (US)	Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale	NASDAQ:VTRS	Viatris Inc
2024/05/09	20 : 47	IH Market News	U.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%	NASDAQ:VTRS	Viatris Inc
2024/05/09	20 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTRS	Viatris Inc
2024/05/09	19 : 59	PR Newswire (US)	Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges	NASDAQ:VTRS	Viatris Inc
2024/05/03	06 : 00	PR Newswire (US)	Viatris to Participate in the BofA Securities 2024 Health Care Conference	NASDAQ:VTRS	Viatris Inc
2024/05/01	19 : 59	PR Newswire (US)	Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health	NASDAQ:VTRS	Viatris Inc
2024/04/17	05 : 30	PR Newswire (US)	Viatris to Report First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:VTRS	Viatris Inc
2024/04/15	21 : 00	PR Newswire (US)	Viatris Appoints Corinne Le Goff as Chief Commercial Officer	NASDAQ:VTRS	Viatris Inc
2024/04/15	19 : 59	PR Newswire (Canada)	Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada	NASDAQ:VTRS	Viatris Inc
2024/04/15	19 : 59	PR Newswire (Canada)	Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au Canada	NASDAQ:VTRS	Viatris Inc
2024/04/01	19 : 59	PR Newswire (US)	Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States	NASDAQ:VTRS	Viatris Inc
2024/03/27	19 : 59	PR Newswire (US)	Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline	NASDAQ:VTRS	Viatris Inc
2024/03/06	10 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/03/06	10 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/03/06	10 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/03/06	09 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/03/06	09 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/03/06	09 : 26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/03/05	08 : 11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTRS	Viatris Inc
2024/02/28	21 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTRS	Viatris Inc
2024/02/28	20 : 30	PR Newswire (US)	Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance	NASDAQ:VTRS	Viatris Inc
2024/02/28	15 : 00	PR Newswire (US)	Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration	NASDAQ:VTRS	Viatris Inc
2024/02/24	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/02/17	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
2024/02/16	07 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTRS	Viatris Inc